Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis

Abstract Contrast-induced acute kidney injury (CIAKI) is an important clinical complication that occurs after the application of contrast agent in percutaneous coronary intervention. The pathogenesis of CIAKI is complex. Studies have shown that cell apoptosis induced by endoplasmic reticulum stress...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuan Wang, Shan Han, Lili Zhao, Hongliang Cong
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-83741-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559483125334016
author Xuan Wang
Shan Han
Lili Zhao
Hongliang Cong
author_facet Xuan Wang
Shan Han
Lili Zhao
Hongliang Cong
author_sort Xuan Wang
collection DOAJ
description Abstract Contrast-induced acute kidney injury (CIAKI) is an important clinical complication that occurs after the application of contrast agent in percutaneous coronary intervention. The pathogenesis of CIAKI is complex. Studies have shown that cell apoptosis induced by endoplasmic reticulum stress (ERS) plays an important role in renal tubular injury in CIAKI. These findings suggest that atorvastatin, probucol and alprostadil can inhibit renal tubular cell apoptosis to prevent CIAKI. However, there is no specific research on the above effects of drug combinations. Therefore, this study aimed to establish a rat CIAKI model with meglumine diatrizoate and add drug intervention to compare the influence of combined drugs with that of atorvastatin alone on CIAKI via the inhibition of ERS-specific molecular chaperones. Fifty Wistar rats were randomly divided into 5 groups: Group A + CC (atorvastatin group, n = 10); Group PA + CC (probucol + atorvastatin group, n = 10); Group AA + CC (alprostadil + atorvastatin group, n = 10); Group PCC (contrast group, n = 10); and Group NCC (control group, n = 10). Among the five groups, Group PCC presented the significantly highest creatinine increase rate and protein and nucleic acid expression levels, with the most severe cell injury and apoptosis observed via HE and TUNEL staining. Compared with those in the atorvastatin group, the rate of increase in creatinine and protein expression in the combined treatment groups were decreased to some extent, and the histological morphology was also improved. This was especially evident in Group AA + CC. Renal cell apoptosis induced by the ERS pathway may play an important role in the pathogenesis of CIAKI induced by meglumine diatrizoate. Atorvastatin, probucol and alprostadil can prevent the occurrence of CIAKI, and the ERS-induced apoptosis pathway is involved in this mechanism. The protective effect of probucol or alprostadil combined with atorvastatin on CIAKI may be stronger than that of atorvastatin alone, with a greater effect of the combination of alprostadil and atorvastatin.
format Article
id doaj-art-09e279f6de26496bbfb1000cbab90315
institution Kabale University
issn 2045-2322
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-09e279f6de26496bbfb1000cbab903152025-01-05T12:27:22ZengNature PortfolioScientific Reports2045-23222024-12-0114111410.1038/s41598-024-83741-5Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosisXuan Wang0Shan Han1Lili Zhao2Hongliang Cong3Department of Cardiac Surgical Intensive Care Unit, Yantai Yuhuangding Hospital, Qingdao University Affiliated HospitalDepartment of Cardiology, Tianjin Chest HospitalTianjin Institute of Cardiovascular Disease, Tianjin Chest HospitalDepartment of Cardiology, Tianjin Chest HospitalAbstract Contrast-induced acute kidney injury (CIAKI) is an important clinical complication that occurs after the application of contrast agent in percutaneous coronary intervention. The pathogenesis of CIAKI is complex. Studies have shown that cell apoptosis induced by endoplasmic reticulum stress (ERS) plays an important role in renal tubular injury in CIAKI. These findings suggest that atorvastatin, probucol and alprostadil can inhibit renal tubular cell apoptosis to prevent CIAKI. However, there is no specific research on the above effects of drug combinations. Therefore, this study aimed to establish a rat CIAKI model with meglumine diatrizoate and add drug intervention to compare the influence of combined drugs with that of atorvastatin alone on CIAKI via the inhibition of ERS-specific molecular chaperones. Fifty Wistar rats were randomly divided into 5 groups: Group A + CC (atorvastatin group, n = 10); Group PA + CC (probucol + atorvastatin group, n = 10); Group AA + CC (alprostadil + atorvastatin group, n = 10); Group PCC (contrast group, n = 10); and Group NCC (control group, n = 10). Among the five groups, Group PCC presented the significantly highest creatinine increase rate and protein and nucleic acid expression levels, with the most severe cell injury and apoptosis observed via HE and TUNEL staining. Compared with those in the atorvastatin group, the rate of increase in creatinine and protein expression in the combined treatment groups were decreased to some extent, and the histological morphology was also improved. This was especially evident in Group AA + CC. Renal cell apoptosis induced by the ERS pathway may play an important role in the pathogenesis of CIAKI induced by meglumine diatrizoate. Atorvastatin, probucol and alprostadil can prevent the occurrence of CIAKI, and the ERS-induced apoptosis pathway is involved in this mechanism. The protective effect of probucol or alprostadil combined with atorvastatin on CIAKI may be stronger than that of atorvastatin alone, with a greater effect of the combination of alprostadil and atorvastatin.https://doi.org/10.1038/s41598-024-83741-5Contrast-induced acute kidney injuryEndoplasmic reticulum stressApoptosisAtorvastatinProbucolAlprostadil
spellingShingle Xuan Wang
Shan Han
Lili Zhao
Hongliang Cong
Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis
Scientific Reports
Contrast-induced acute kidney injury
Endoplasmic reticulum stress
Apoptosis
Atorvastatin
Probucol
Alprostadil
title Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis
title_full Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis
title_fullStr Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis
title_full_unstemmed Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis
title_short Combination drug therapy prevents CIAKI by suppressing ER stress-induced apoptosis
title_sort combination drug therapy prevents ciaki by suppressing er stress induced apoptosis
topic Contrast-induced acute kidney injury
Endoplasmic reticulum stress
Apoptosis
Atorvastatin
Probucol
Alprostadil
url https://doi.org/10.1038/s41598-024-83741-5
work_keys_str_mv AT xuanwang combinationdrugtherapypreventsciakibysuppressingerstressinducedapoptosis
AT shanhan combinationdrugtherapypreventsciakibysuppressingerstressinducedapoptosis
AT lilizhao combinationdrugtherapypreventsciakibysuppressingerstressinducedapoptosis
AT hongliangcong combinationdrugtherapypreventsciakibysuppressingerstressinducedapoptosis